Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Main Index

View All
Anti-spasticity agents
Anti-staphylococcal antibiotics
Antistreptolysin
Anti-syphon device
Antithrombin III Deficiency Chronic Diseases and Pregnancy Evaluation of Thrombophilia
A10BX10 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Insulin Therapy in Type 2 Diabetes Unintentional Weight Loss in Adults
A11CC01 Pharmacological Glucocorticoid Treatment Psoriasis Renal Disease in Children (Nephrotic and Nephritic Syndrome) Vitamins
A11CC02 Hypocalcaemia, Hypoparathyroidism and Vitamin D Deficiency Pharmacological Glucocorticoid Treatment Psoriasis Renal Disease in Children (Nephrotic and Nephritic Syndrome)
A11CC03 Hypocalcaemia, Hypoparathyroidism and Vitamin D Deficiency Pharmacological Glucocorticoid Treatment Psoriasis Renal Disease in Children (Nephrotic and Nephritic Syndrome) Treatment of Chronic Renal Failure
A11CC04 Pharmacological Glucocorticoid Treatment Psoriasis Renal Disease in Children (Nephrotic and Nephritic Syndrome)
Antithrombin III
Antithrombin
Antithrombotic Agents in Primary Health Care
Antithrombotic agents
Antithrombotic drugs
Antithrombotic prophylaxis
Antithrombotic therapy
Antithrombotic treatment
Antithyroid Agents
anti-TNFα antibody
Antitubercular Agents Antitubercular Medication in Ambulatory Care Directly Observed Therapy (Dot) in Tuberculosis Treatment Fluoroquinolones for Treating Tuberculosis
Antitubercular Medication in Ambulatory Care
Antitubercular medication
Antitumour antibiotics
Antitussive Agents Over-the-Counter Antitussives for Acute Cough Symptomatic Treatment of the Cough in Whooping Cough
Antitussives
Anti-Ulcer Agents Helicobacter Pylori Eradication or Antisecretory Therapy for Rebleeding from Peptic Ulcer Proton Pump Inhibitor Treatment Initiated Prior to Endoscopic Diagnosis in Upper Gastrointestinal Bleeding
Anti-vascular endothelial growth factor
anti-VEGF agents Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration Anti-Vegf for Macular Oedema Secondary to Central Retinal Vein Occlusion
anti-VEGF